Breaking News: FDA Approves First Generic Victoza (Liraglutide Injection) for Type 2 Diabetes The #FDA #approved the first generic version of #Victoza (liraglutide injection), offering a more affordable option for managing type 2 #diabetes in adults and children aged 10 and older
The interaction between tirzepatide and levothyroxine is well-documented, predictable, and manageable with the right monitoring protocol
In addition to dietary intake, malabsorption conditions like celiac disease, atrophic gastritis, and inflammatory bowel diseases, all of autoimmune nature and frequently associated with autoimmune thyroid diseases, must be taken into account when vitamin B12 requirements are evaluated [97,98,99]
Endogenous hyperinsulinemia may cause weight gain and obesity [30], and treatment with insulin causes substantial weight gain, and may even increase cardiovascular risk [31]